← Eichor
Condition: Atopic Asthma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Atopic Asthma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04891237ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
Phase N/A · 1 location(s) · Celltrion HealthCare France · NCT07425639Deployment o the Multidisciplinary Prospective Cohort Imminent
NA · 1 location(s) · University Hospital, Lille · NCT04334031Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Phase 2 · 1 location(s) · Longbio Pharma · NCT07342803Viral Mucosal Reprogramming
Phase 2 · 1 location(s) · The University of Texas Medical Branch, Galveston · NCT05331170Omalizumab Before Onset of Exacerbations
Phase 2 · 1 location(s) · Children's National Research Institute · NCT05332067Prospective Longitudinal Observational Research in Atopic Dermatitis
Phase N/A · 1 location(s) · University of Zurich · NCT04240522Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
Phase 2 · 13 location(s) · Oneness Biotech Co., Ltd. · NCT05008965Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Ast
Phase 1/Phase 2 · 1 location(s) · University of Zurich · NCT06960382Allergy and Immunology Natural History Study
Phase N/A · 1 location(s) · Columbia University · NCT05584488Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
Phase N/A · 1 location(s) · First Affiliated Hospital of Ningbo University · NCT07313904Innate Immunity in Allergic Asthma
Phase N/A · 1 location(s) · University of Central Florida · NCT06068335Nationwide Research on the Rewilding of Kindergarten Yards
NA · 2 location(s) · Natural Resources Institute Finland · NCT06390878Microbiome and Atopy in Mali
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07051902Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Phase 3 · 27 location(s) · Inmunotek S.L. · NCT04898283Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NA · 6 location(s) · University of Melbourne · NCT07055542NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
Phase N/A · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT02327897A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06732414Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04435990Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
Phase 3 · 19 location(s) · Inmunotek S.L. · NCT07348302Restoration of Microbiota in Neonates
NA · 1 location(s) · Karolinska Institutet · NCT03928431Plant Stanol Esters and Preventing Asthma Symptoms
NA · 1 location(s) · Maastricht University Medical Center · NCT03983603Short Treatment with Omalizumab for Severe Asthma
Phase 4 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04763447Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
NA · 1 location(s) · Fraunhofer-Institute of Toxicology and Experimental Medicine · NCT06317909
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.